Public Summary Documents – September 2022 PBAC meeting

11 November 2022 - The Public Summary Document for tixagevimab and cilgavimab (Evusheld) from the September 2022 PBAC intracycle meeting is ...

Read more →

Public Summary Documents (first time decisions not to recommend and deferrals) - July 2022 PBAC meeting

11 November 2022 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the July 2022 PBAC ...

Read more →

MSAC can't find a place for Carvykti

10 November 2022 - The outcome from Janssen's application requesting the public funding of ciltacabtagene autoleucel for the treatment of ...

Read more →

New COVID-19 variant leads to increase in cases

8 November 2022 - A statement from Professor Paul Kelly, Australian Government Chief Medical Officer, on the increase in COVID-19 cases ...

Read more →

Independent review into Medicare compliance

5 November 2022 - The Albanese Government has appointed respected health economist Dr Pradeep Philip to conduct an independent review into ...

Read more →

Changes announced to Rebif listing on PBS

3 November 2022 - From 1 December 2022, Rebif will no longer be available on the PBS for Australians living with ...

Read more →

Outcome statement - September 2022 DUSC meeting

3 November 2022 - The outcome statement from the September 2022 DUSC meeting is now available. ...

Read more →

Department tweaks the agenda for the Nov 2022 PBAC meeting yet again

2 November 2022 - Two changes made on the eve of the meeting. ...

Read more →

First immunotherapy for patients with a potentially life threatening type of non-melanoma skin cancer now available on the PBS

1 November 2022 - Australians with a potentially life-threatening type of non-melanoma skin cancer will for the first time, have ...

Read more →

Schedule of Pharmaceutical Benefits - 1 November 2022

1 November 2022 - The November 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

1 November 2022 updates as part of the digital transformation of Authority Required (Written) PBS listings

1 November 2022 - From 1 November 2022, the PBS listings for certain medicines will be updated as part of the ...

Read more →

Expanded access to COVID-19 oral antiviral treatments on the PBS

1 November 2022 - Expanded eligibility criteria for COVID-19 oral anti-viral treatments (Lagevrio (molnupiravir) and Paxlovid (nirmatrelvir and ritonavir) ...

Read more →

Department of Health tweaks the agenda for this week's PBAC meeting

28 October 2022 - The is one late change to the agenda for the November meeting. ...

Read more →

Public Summary Documents – July 2022 PBAC meeting

28 October 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2022 PBAC ...

Read more →

TGA provisionally approves Pfizer bivalent COVID-19 vaccine for use as a booster dose in adults

28 October 2022 - On 27 October 2022, the TGA provisionally approved Pfizer’s bivalent COVID-19 vaccine, tozinameran and riltozinameran (COMIRNATY Original/Omicron ...

Read more →